TEVA Cash & Equivalents

Teva Pharmaceutical Industries Limited American Depositary Shares · Cash & Equivalents

TEVA logo

TEVA Cash & Equivalents

Latest reported$3.56B
TEVA FY Cash & Equivalents ($22.40M → $3.56B)
High-resolution chart · PNG

TEVA cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
3,555,945,000
3,300,000,000
3,226,000,000
2,801,000,000
2,165,000,000
2,177,000,000
1,975,000,000
1,782,000,000
963,000,000
988,000,000
6,946,000,000
2,226,000,000
1,038,000,000
2,879,000,000
1,096,000,000
1,248,000,000
1,995,000,000
1,854,000,000
1,488,000,000
1,332,000,000
1,275,600,000
784,100,000
1,057,300,000
809,900,000
768,918,000
420,634,000
77,177,000
47,100,000
50,900,000
61,200,000
63,400,000
42,400,000
39,900,000
13,800,000
7,900,000
15,400,000
4,600,000
13,100,000
15,900,000
22,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.